{
    "paper_id": "PMC3320222",
    "metadata": {
        "title": "Inpatient Capacity at Children\u2019s Hospitals during Pandemic (H1N1) 2009 Outbreak, United States",
        "authors": [
            {
                "first": "Marion",
                "middle": [
                    "R."
                ],
                "last": "Sills",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Matthew",
                "middle": [],
                "last": "Hall",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Evan",
                "middle": [
                    "S."
                ],
                "last": "Fieldston",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Paul",
                "middle": [
                    "D."
                ],
                "last": "Hain",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Harold",
                "middle": [
                    "K."
                ],
                "last": "Simon",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Thomas",
                "middle": [
                    "V."
                ],
                "last": "Brogan",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Daniel",
                "middle": [
                    "B."
                ],
                "last": "Fagbuyi",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Michael",
                "middle": [
                    "B."
                ],
                "last": "Mundorff",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Samir",
                "middle": [
                    "S."
                ],
                "last": "Shah",
                "suffix": "",
                "email": null,
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "Medscape, LLC is pleased to provide online continuing medical education (CME) for this journal article, allowing clinicians the opportunity to earn CME credit.",
            "cite_spans": [],
            "section": "MEDSCAPE CME",
            "ref_spans": []
        },
        {
            "text": "This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Medscape, LLC and Emerging Infectious Diseases. Medscape, LLC is accredited by the ACCME to provide continuing medical education for physicians.",
            "cite_spans": [],
            "section": "MEDSCAPE CME",
            "ref_spans": []
        },
        {
            "text": "Medscape, LLC designates this Journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.",
            "cite_spans": [],
            "section": "MEDSCAPE CME",
            "ref_spans": []
        },
        {
            "text": "All other clinicians completing this activity will be issued a certificate of participation. To participate in this journal CME activity: (1) review the learning objectives and author disclosures; (2) study the education content; (3) take the post-test with a 70% minimum passing score and complete the evaluation at www.medscape.org/journal/eid; (4) view/print certificate.",
            "cite_spans": [],
            "section": "MEDSCAPE CME",
            "ref_spans": []
        },
        {
            "text": "Release date: August 23, 2011; Expiration date: August 23, 2012",
            "cite_spans": [],
            "section": "MEDSCAPE CME",
            "ref_spans": []
        },
        {
            "text": "Upon completion of this activity, participants will be able to:",
            "cite_spans": [],
            "section": "Learning Objectives",
            "ref_spans": []
        },
        {
            "text": "Karen Foster, Technical Writer/Editor, Emerging Infectious Diseases. Disclosure: Karen Foster has disclosed no relevant financial relationships.",
            "cite_spans": [],
            "section": "MEDSCAPE CME EDITOR",
            "ref_spans": []
        },
        {
            "text": "Charles P. Vega, MD, Associate Professor; Residency Director, Department of Family Medicine, University of California, Irvine. Disclosure: Charles P. Vega, MD, has disclosed no relevant financial relationships.",
            "cite_spans": [],
            "section": "MEDSCAPE CME AUTHOR",
            "ref_spans": []
        },
        {
            "text": "Disclosures: Matthew Hall, PhD; Evan S. Fieldston, MD, MBA, MSHP; Paul D. Hain, MD; Thomas V. Brogan, MD; and Michael B. Mundorff, MBA, MHSA, have disclosed no relevant financial relationships. Marion R. Sills, MD, MPH, has disclosed the following relevant financial relationships: received grants for clinical research from Agency for Healthcare Research and Quality. Harold K. Simon, MD, MBA, has disclosed the following relevant financial relationships: received grants for clinical research from Baxter International Inc. (rehydration clinical trial); AspenBio Pharma, Inc (appendicitis screening); National Institutes of Health (progesterone planning trial through the Pediatric Applied Research Network), all through Emory University. Daniel B. Fagbuyi, MD, has disclosed the following relevant financial relationships: owns stock, stock options, or bonds from Medco Health Solutions, Inc.; Orexigen Therapeutics, Inc. Samir S. Shah, MD, MSCE, has disclosed the following relevant financial relationships: received grants for clinical research from National Institutes of Health; Agency for Healthcare Research and Quality; Robert Wood Johnson Foundation.",
            "cite_spans": [],
            "section": "AUTHORS",
            "ref_spans": []
        }
    ],
    "ref_entries": {
        "FIGREF0": {
            "text": "Figure: Predictive model of hospital occupancy during 11-week outbreak of pandemic influenza A (H1N1) 2009 in the United States, by ED IRI admission rate and ED IRI volume, using fall 2009 pandemic period data as baseline. Percentages given indicate hospital admission rate during period or for hypothetical scenario. Gray area indicates 100% occupancy. Each circle represents median occupancy from 1 hospital; vertical whiskers indicate interquartile range. y-axes indicate percentage occupancy; x-axes indicates individual hospitals. Median (interquartile range) occupancy across study hospitals: A) 95.9% (85.0%\u2013100.3%); B) 97.9% (80.5%\u2013102.7%); C) 109.7% (97.9%\u2013117.1%); D) 102.2% (91.7%\u2013112.4%); E) 108.0% (96.4%\u2013114.9%); F) 132.4% (124.5%\u2013145.5%). Letters correspond to scenarios in Table 3. *MMWR reporting weeks 35\u201345 (September 5\u2013November 20, 2009). \u2020MMWR reporting weeks 44\u201353 (November 1, 2003\u2013January 9, 2004). ED, emergency department; IRI, influenza-related illness; MMWR, Morbidity and Mortality Weekly Report (Centers for Disease Control and Prevention, Atlanta, GA, USA).",
            "type": "figure"
        }
    },
    "back_matter": [],
    "bib_entries": {}
}